Burden of non-communicable diseases in Iran: past, present, and future

Aminorroaya, Arya; Fattahi, Nima; Azadnajafabad, Sina; Mohammadi, Esmaeil; Jamshidi, Kosar; Khalilabad, Mahtab Rouhifard; Fateh, Sahar Mohammadi; Naderimagham, Shohreh; Rezaei, Negar; Larijani, Bagher; Farzadfar, Farshad

doi:10.1007/s40200-020-00669-z

Cited by 37 publications

(36 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The lower mortality rates in these countries, however, are mainly the result of early detection, better healthcare access, and suitable treatment. 2,13,38 In this study, the increase of TC burden was significant in every measure, including DALY, YLL, and YLD. The overall 10-year survival rate for most treatable types of TC was estimated at 92%-98%, except for incurable types like anaplastic thyroid carcinoma.…”

Section: Discussionmentioning

confidence: 53%

“…In developed countries, a possible explanation for the higher incidence might be more exposure to environmental risk factors such as ionizing radiation and other carcinogens and more access to diagnostic tools. The lower mortality rates in these countries, however, are mainly the result of early detection, better healthcare access, and suitable treatment 2,13,38 . In this study, the increase of TC burden was significant in every measure, including DALY, YLL, and YLD.…”

Section: Discussionmentioning

confidence: 56%

See 1 more Smart Citation

Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 53%

Section: Discussionmentioning

confidence: 56%

Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…Analysis of primary epidemiologic indices of HMs demonstrates impressive alteration from 1990 to 2017, with increases in ASIR for all hematologic malignancies with the exception of leukemia, ALL, and CML, which may have been driven by new screening strategies and increasing risk factors [ 4 , 26 , 27 ]. The decreases in the death rate of almost all of the HMs could be explained by treatment improvement and increased access to cancer care [ 28 ].…”

Section: Discussionmentioning

confidence: 99%

A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017

et al. 2021

Self Cite

View full text Add to dashboard Cite

Background Hematologic malignancies (HMs) are a heterogeneous group of cancers that comprise diverse subgroups of neoplasms. So far, despite the major epidemiologic concerns about the quality of care, limited data are available for patients with HMs. Thus, we created a novel measure—Quality of Care Index (QCI)—to appraise the quality of care in different populations. Methods The Global Burden of Disease data from 1990 to 2017 applied in our study. We performed a principal component analysis on several secondary indices from the major primary indices, including incidence, prevalence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years (DALYs) to create the QCI, which provides an overall score of 0–100 of the quality of cancer care. We estimated the QCI for each age group on different scales and constructed the gender disparity ratio to evaluate the gender disparity of care in HMs. Results Globally, while the overall age-standardized incidence rate of HMs increased from 1990 to 2017, the age-standardized DALYs and death rates decreased during the same period. Across countries, in 2017, Iceland (100), New Zealand (100), Australia (99.9), and China (99.3) had the highest QCI scores for non-Hodgkin lymphoma, multiple myeloma, Hodgkin lymphoma, and leukemia. Conversely, Central African Republic (11.5 and 6.1), Eritrea (9.6), and Mongolia (5.4) had the lowest QCI scores for the mentioned malignancies respectively. Overall, the QCI score was positively associated with higher sociodemographic of nations, and was negatively associated with age advancing. Conclusions The QCI provides a robust metric to evaluate the quality of care that empowers policymakers on their responsibility to allocate the resources effectively. We found that there is an association between development status and QCI and gender equity, indicating that instant policy attention is demanded to improve health-care access.

show abstract

“…This finding points to the notion that care quality requires great resource allocation [ 12 ]. As the burden on health systems is transitioning from communicable diseases toward non-communicable diseases, especially in developing countries, it is anticipated that the gap between regions will become more pronounced [ 26 , 27 ]. CNS cancers usually are considered when focal neurologic symptoms emerge, not in routine general clinic visits.…”

Section: Discussionmentioning

confidence: 99%

A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017

et al. 2021

Self Cite

View full text Add to dashboard Cite

Primary brain and other central nervous system (CNS) cancers cause major burdens. In this study, we introduced a measure named the Quality of Care Index (QCI), which indirectly evaluates the quality of care given to patients with this group of cancers. Here we aimed to compare different geographic and socioeconomic patterns of CNS cancer care according to the novel measure introduced. In this regard, we acquired age-standardized primary epidemiologic measures were acquired from the Global Burden of Disease (GBD) study 1990-2017. The primary measures were combined to make four secondary indices which all of them indirectly show the quality of care given to patients. Principal Component Analysis (PCA) method was utilized to calculate the essential component named QCI. Further analyses were made based on QCI to assess the quality of care globally, regionally, and nationally (with a scale of 0-100 which higher values represent better quality of care). For 2017, the global calculated QCI was 55.0. QCI showed a desirable condition in higher socio-demographic index (SDI) quintiles. Oppositely, low SDI quintile countries (7.7) had critically worse care quality. Western Pacific Region with the highest (76.9) and African Region with the lowest QCIs (9.9) were the two WHO regions extremes. Singapore was the country with the maximum QCI of 100, followed by Japan (99.9) and South Korea (98.9). In contrast, Swaziland (2.5), Lesotho (3.5), and Vanuatu (3.9) were countries with the worse condition. While the quality of care for most regions was desirable, regions with economic constraints showed to have poor quality of care and require enforcements toward this lethal diagnosis.

show abstract

Burden of non-communicable diseases in Iran: past, present, and future

Cited by 37 publications

References 19 publications

Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017

Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017

A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017

A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017

Contact Info

Product

Resources

About